Log in to save to my catalogue

Stem cell‐derived mitochondria transplantation: A promising therapy for mitochondrial encephalomyopa...

Stem cell‐derived mitochondria transplantation: A promising therapy for mitochondrial encephalomyopa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8193690

Stem cell‐derived mitochondria transplantation: A promising therapy for mitochondrial encephalomyopathy

About this item

Full title

Stem cell‐derived mitochondria transplantation: A promising therapy for mitochondrial encephalomyopathy

Publisher

England: John Wiley & Sons, Inc

Journal title

CNS neuroscience & therapeutics, 2021-07, Vol.27 (7), p.733-742

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Mitochondrial encephalomyopathies are disorders caused by mitochondrial and nuclear DNA mutations which affect the nervous and muscular systems. Current therapies for mitochondrial encephalomyopathies are inadequate and mostly palliative. However, stem cell‐derived mitochondria transplantation has been demonstrated to play an key part in metabolic...

Alternative Titles

Full title

Stem cell‐derived mitochondria transplantation: A promising therapy for mitochondrial encephalomyopathy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8193690

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8193690

Other Identifiers

ISSN

1755-5930

E-ISSN

1755-5949

DOI

10.1111/cns.13618

How to access this item